{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:10:38Z","timestamp":1780625438173,"version":"3.54.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T00:00:00Z","timestamp":1355184000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0047982","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T21:45:17Z","timestamp":1355262317000},"page":"e47982","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Outcomes of Sustained-Release Formulation of Valproate and Topiramate Monotherapy in Patients with Epilepsy: A Multi-Centre, Cohort Study"],"prefix":"10.1371","volume":"7","author":[{"given":"Yida","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xishun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinglie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangshu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqin","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1528-1157.1997.tb01224.x","article-title":"Commission on European Affairs: appropriate standards of epilepsy care across Europe.ILEA","volume":"38","author":"MJ Brodie","year":"1997","journal-title":"Epilepsia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(04)00882-8","article-title":"Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines","volume":"3","author":"E Beghi","year":"2004","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1474-4422(04)00935-4","article-title":"Current drug treatment of epilepsy in adults","volume":"3","author":"D McCorry","year":"2004","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"AG Marson","year":"2007","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","article-title":"Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine\/Carbamazepine Monotherapy Trial Group","volume":"345","author":"MJ Brodie","year":"1995","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00415-004-0344-0","article-title":"Drug selection for the newly diagnosed patient: when is a new generation antiepileptic drug indicated","volume":"251","author":"T Tomson","year":"2004","journal-title":"J Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa0902014","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy","volume":"362","author":"TA Glauser","year":"2010","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/bmj.328.7451.1273","article-title":"NICE guidance on newer drugs for epilepsy in adults","volume":"328","author":"E Perucca","year":"2004","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJM200006223422511","article-title":"Randomized trials or observational tribulations?","volume":"342","author":"SJ Pocock","year":"2000","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(98)09102-8","article-title":"Can randomised trials inform clinical decisions about individual patients","volume":"353","author":"D Mant","year":"1999","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bmj.328.7430.39","article-title":"Assessing the quality of research","volume":"328","author":"P Glasziou","year":"2004","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"AG Marson","year":"2007","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0404.2003.00093.x","article-title":"Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy","volume":"107","author":"MD Privitera","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","year":"1981","journal-title":"Epilepsia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1528-1157.2002.20801.x","article-title":"Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis","volume":"43","author":"AG Marson","year":"2002","journal-title":"Epilepsia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1528-1157.2000.tb00165.x","article-title":"Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy","volume":"41","author":"SD Lhatoo","year":"2000","journal-title":"Epilepsia"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00381-010-1255-2","article-title":"Retrospective analysis of the effectiveness of first-line antiepileptic drugs for generalized onset and unclassified epileptic seizures in Chinese children","volume":"27","author":"YX Ding","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1528-1157.1998.tb01167.x","article-title":"Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy","volume":"39","author":"D Chadwick","year":"1998","journal-title":"Epilepsia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/j.1528-1167.2009.02177.x","article-title":"Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study","volume":"50","author":"YJ Cho","year":"2009","journal-title":"Epilepsia"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/01.WNL.0000048200.12663.BC","article-title":"A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy","volume":"60","author":"FG Gilliam","year":"2003","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0149-2918(08)80045-8","article-title":"Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy","volume":"30","author":"E Ben Menachem","year":"2008","journal-title":"Clin Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.yebeh.2004.03.002","article-title":"Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center","volume":"5","author":"HP Bootsma","year":"2004","journal-title":"Epilepsy Behav"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1017\/S0317167100034855","article-title":"Topiramate\u2013safety and tolerability","volume":"25","author":"MW Jones","year":"1998","journal-title":"Can J Neurol Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/bmj.315.7123.1636","article-title":"Choosing the best research design for each question","volume":"315","author":"DL Sackett","year":"1997","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(02)07500-1","article-title":"Cohort studies: marching towards outcomes","volume":"359","author":"DA Grimes","year":"2002","journal-title":"Lancet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0047982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T22:03:01Z","timestamp":1540245781000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0047982"}},"subtitle":[],"editor":[{"given":"James M.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,11]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0047982","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,11]]}}}